Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre

Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods. Outcomes following IGB treatment in 135 patients with obesity and...

Full description

Saved in:
Bibliographic Details
Published inCanadian journal of gastroenterology & hepatology Vol. 2017; no. 2017; pp. 1 - 8
Main Authors Oben, Jude A., Solis-Cuevas, Alessandro, Ray, Shuvra, Cordero, Paul, Gan, Jaslyn, Li, Jiawei, Nguyen, Vi, Khatib, Mai
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Publishing Corporation 01.01.2017
Hindawi
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods. Outcomes following IGB treatment in 135 patients with obesity and NAFLD (mean baseline weight 117.9 kg; BMI 41.7 kg/m2; HOMA-IR 3.6) were retrospectively examined. Clinical, anthropometric, and biochemical changes were analysed at six months and after consecutive treatment with two and three serial IGBs. Results. After six months, significant changes were seen with weight and BMI (mean reductions of 11.3 kg and 4.1 kg/m2, resp., p<0.01 for both). Significant improvements were also seen with ALT, GGT, and HOMA-IR, with all changes corresponding with weight loss. Forty-eight patients received two IGBs, and 20 were treated with three serial IGBs. The greatest amount of total weight loss was observed after the first 6 months (mean weight lost 7.4 kg, versus 3.6 kg and 1.9 kg with two and three IGBs, resp.). Conclusions. IGB therapy is an effective, alternative nonsurgical means for weight loss in the management of obesity and NAFLD over the short term, with greatest outcomes observed after six months. Improvements in insulin resistance and hepatic transaminases correlated with weight change.
AbstractList Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods. Outcomes following IGB treatment in 135 patients with obesity and NAFLD (mean baseline weight 117.9 kg; BMI 41.7 kg/m2; HOMA-IR 3.6) were retrospectively examined. Clinical, anthropometric, and biochemical changes were analysed at six months and after consecutive treatment with two and three serial IGBs. Results. After six months, significant changes were seen with weight and BMI (mean reductions of 11.3 kg and 4.1 kg/m2, resp., p<0.01 for both). Significant improvements were also seen with ALT, GGT, and HOMA-IR, with all changes corresponding with weight loss. Forty-eight patients received two IGBs, and 20 were treated with three serial IGBs. The greatest amount of total weight loss was observed after the first 6 months (mean weight lost 7.4 kg, versus 3.6 kg and 1.9 kg with two and three IGBs, resp.). Conclusions. IGB therapy is an effective, alternative nonsurgical means for weight loss in the management of obesity and NAFLD over the short term, with greatest outcomes observed after six months. Improvements in insulin resistance and hepatic transaminases correlated with weight change.
Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods. Outcomes following IGB treatment in 135 patients with obesity and NAFLD (mean baseline weight 117.9 kg; BMI 41.7kg/[m.sup.2]; HOMA-IR 3.6) were retrospectively examined. Clinical, anthropometric, and biochemical changes were analysed at six months and after consecutive treatment with two and three serial IGBs. Results. After six months, significant changes were seen with weight and BMI (mean reductions of 11.3 kg and 4.1kg/[m.sup.2],resp., p < 0.01 for both). Significant improvements were also seen with ALT, GGT, and HOMAIR, with all changes corresponding with weight loss. Forty-eight patients received two IGBs, and 20 were treated with three serial IGBs. The greatest amount of total weight loss was observed after the first 6 months (mean weight lost 7.4 kg, versus 3.6 kg and 1.9 kg with two and three IGBs, resp.). Conclusions. IGB therapy is an effective, alternative nonsurgical means for weight loss in the management of obesity and NAFLD over the short term, with greatest outcomes observed after six months. Improvements in insulin resistance and hepatic transaminases correlated with weight change.
The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Outcomes following IGB treatment in 135 patients with obesity and NAFLD (mean baseline weight 117.9 kg; BMI 41.7 kg/m ; HOMA-IR 3.6) were retrospectively examined. Clinical, anthropometric, and biochemical changes were analysed at six months and after consecutive treatment with two and three serial IGBs. After six months, significant changes were seen with weight and BMI (mean reductions of 11.3 kg and 4.1 kg/m , resp., < 0.01 for both). Significant improvements were also seen with ALT, GGT, and HOMA-IR, with all changes corresponding with weight loss. Forty-eight patients received two IGBs, and 20 were treated with three serial IGBs. The greatest amount of total weight loss was observed after the first 6 months (mean weight lost 7.4 kg, versus 3.6 kg and 1.9 kg with two and three IGBs, resp.). IGB therapy is an effective, alternative nonsurgical means for weight loss in the management of obesity and NAFLD over the short term, with greatest outcomes observed after six months. Improvements in insulin resistance and hepatic transaminases correlated with weight change.
Background . The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods . Outcomes following IGB treatment in 135 patients with obesity and NAFLD (mean baseline weight 117.9 kg; BMI 41.7 kg/m 2 ; HOMA-IR 3.6) were retrospectively examined. Clinical, anthropometric, and biochemical changes were analysed at six months and after consecutive treatment with two and three serial IGBs. Results . After six months, significant changes were seen with weight and BMI (mean reductions of 11.3 kg and 4.1 kg/m 2 , resp., p < 0.01 for both). Significant improvements were also seen with ALT, GGT, and HOMA-IR, with all changes corresponding with weight loss. Forty-eight patients received two IGBs, and 20 were treated with three serial IGBs. The greatest amount of total weight loss was observed after the first 6 months (mean weight lost 7.4 kg, versus 3.6 kg and 1.9 kg with two and three IGBs, resp.). Conclusions . IGB therapy is an effective, alternative nonsurgical means for weight loss in the management of obesity and NAFLD over the short term, with greatest outcomes observed after six months. Improvements in insulin resistance and hepatic transaminases correlated with weight change.
Audience Academic
Author Cordero, Paul
Solis-Cuevas, Alessandro
Oben, Jude A.
Ray, Shuvra
Khatib, Mai
Gan, Jaslyn
Li, Jiawei
Nguyen, Vi
AuthorAffiliation 3 Department of Biological Sciences, University College London, Gower St., Bloomsbury, London WC1E 6BT, UK
1 Institute for Liver and Digestive Health, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK
2 Department of Gastroenterology and Hepatology, Guy's and St Thomas' Hospital, NHS Foundation Trust, Westminster Bridge Rd., London SE1 7EH, UK
AuthorAffiliation_xml – name: 1 Institute for Liver and Digestive Health, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK
– name: 3 Department of Biological Sciences, University College London, Gower St., Bloomsbury, London WC1E 6BT, UK
– name: 2 Department of Gastroenterology and Hepatology, Guy's and St Thomas' Hospital, NHS Foundation Trust, Westminster Bridge Rd., London SE1 7EH, UK
Author_xml – sequence: 1
  fullname: Oben, Jude A.
– sequence: 2
  fullname: Solis-Cuevas, Alessandro
– sequence: 3
  fullname: Ray, Shuvra
– sequence: 4
  fullname: Cordero, Paul
– sequence: 5
  fullname: Gan, Jaslyn
– sequence: 6
  fullname: Li, Jiawei
– sequence: 7
  fullname: Nguyen, Vi
– sequence: 8
  fullname: Khatib, Mai
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29441342$$D View this record in MEDLINE/PubMed
BookMark eNqNksFv0zAUhyM0xMbYjTOyQOIC3WLHiePLpFEYVKroYeNsvdgvravU7ux0U_nrcWnpVmkH5IPt58-f7Kff6-zIeYdZ9pbm55SW5QXLqbjglRRU8hfZCWOSDpiQ4mi_ruVxdhbjPM9zyspSFuxVdswk57Tg7CT7PVn12i8wktZ3nX-wbkpuMFjoyMj1AaYQ-2A1-QLp1DtyO8MAy3WiA5k0GG2_JuAM-ekddNrPfJfga-hTeWzvMZCvNiJEJNYRIDdJ3yEZYlLjm-xlC13Es918mv26_nY7_DEYT76Phlfjga4q1g8AuZDcSFqyPK1qwKo0BgvKZCOgaijjVaU5pJ8KkLoCBGyK1hStNoyLpjjNRluv8TBXy2AXENbKg1V_Cz5MFYTe6g5VXuS1NhTa2lBeyLbRkHapKmkjQWNyXW5dy1WzQKM3H4HuQHp44uxMTf29KkVZ15wnwYedIPi7FcZezf0qpN5FRWVdUVHKunikppBeZV3rk0wvbNTqqqwrxvNKyES9f4bSS3unnkLnz0BpGFxYndLU2lQ_sH58cmGG0PWz6LtVb72Lh-DnLaiDjzFgu28DzdUmnWqTTrVLZ8LfPW3dHv6XxQR82gIz6ww82P_UYWKwhUea8jRE8QffqfaH
CitedBy_id crossref_primary_10_1016_j_jhep_2019_07_026
crossref_primary_10_2174_1570161121666221118155136
crossref_primary_10_1007_s10620_022_07596_4
crossref_primary_10_1016_j_jdcr_2023_01_035
crossref_primary_10_14309_ctg_0000000000000364
crossref_primary_10_3390_medicina57080737
crossref_primary_10_1007_s11901_019_00498_6
crossref_primary_10_1111_apt_17805
crossref_primary_10_1111_liv_14441
crossref_primary_10_4254_wjh_v14_i9_1704
crossref_primary_10_1080_17512433_2021_1917374
crossref_primary_10_1097_CLD_0000000000000126
crossref_primary_10_1016_j_cgh_2019_07_009
crossref_primary_10_3389_fendo_2022_931519
crossref_primary_10_1590_0102_672020230002e1731
crossref_primary_10_1016_j_cld_2023_01_009
crossref_primary_10_1007_s11695_020_05084_0
crossref_primary_10_1055_a_1946_6285
Cites_doi 10.1038/nrdp.2017.34
10.1016/S0016-5107(04)02406-X
10.1186/1756-0500-7-242
10.1007/s00592-013-0516-4
10.1038/sj.ijo.0802305
10.1136/bmj.d6891
10.1016/j.bpg.2014.07.008
10.1053/j.gastro.2005.04.014
10.1097/SLE.0000000000000440
10.1016/j.gie.2009.06.036
10.1111/jpn.12283
10.1001/jama.2014.5988
10.1007/s11695-007-9331-8
10.1007/s11695-012-0829-3
10.1038/sj.ijo.0803094
10.1007/s11695-007-9383-9
10.1136/gutjnl-2013-304490
10.5114/wiitm.2015.55748
10.1053/j.gastro.2010.09.038
10.3390/ijms17060947
10.1016/j.gie.2012.05.023
10.1097/MCO.0000000000000179
10.1002/hep.24127
10.1007/s11695-010-0231-y
10.1093/ajcn/78.6.1079
10.1159/000282080
10.1007/BF00280883
10.1002/hep.21327
10.4137/IMI.S31451
10.1053/j.gastro.2011.06.061
10.1089/met.2015.0095
10.1381/0960892055002202
10.1016/j.jhep.2016.12.022
10.1016/j.cgh.2012.10.001
10.1056/NEJMoa021423
10.1016/s0140-6736(14)61316-7
10.4324/9780203987858
ContentType Journal Article
Copyright Copyright © 2017 Vi Nguyen et al.
COPYRIGHT 2018 Hindawi Limited
Copyright © 2017 Vi Nguyen et al.; This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2017 Vi Nguyen et al. 2017
Copyright_xml – notice: Copyright © 2017 Vi Nguyen et al.
– notice: COPYRIGHT 2018 Hindawi Limited
– notice: Copyright © 2017 Vi Nguyen et al.; This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright © 2017 Vi Nguyen et al. 2017
DBID ADJCN
AHFXO
RHU
RHW
RHX
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8FQ
8FV
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
5PM
DOA
DOI 10.1155/2017/4697194
DatabaseName الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Canadian Business & Current Affairs Database
Canadian Business & Current Affairs Database (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
CBCA Complete (Alumni Edition)
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
CBCA Complete
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList

MEDLINE


Publicly Available Content Database
CrossRef

Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2291-2797
Editor Filipović, Branka
Editor_xml – sequence: 1
  givenname: Branka
  surname: Filipović
  fullname: Filipović, Branka
EndPage 8
ExternalDocumentID oai_doaj_org_article_0308cd1af8d1439fbcad1a03091b9ace
A586240679
10_1155_2017_4697194
29441342
1141417
Genre Evaluation Studies
Journal Article
GeographicLocations London England
GeographicLocations_xml – name: London England
GrantInformation_xml – fundername: Obesity Action Campaign
GroupedDBID 24P
3V.
53G
5VS
7X7
88E
8FI
8FJ
8FQ
AAFWJ
AAJEY
ABUWG
ADBBV
ADJCN
AFKRA
AFPKN
AHFXO
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DWQXO
EBD
EBS
EJD
EMOBN
FYUFA
GROUPED_DOAJ
H13
HMCUK
HYE
IAO
ICQ
IEA
IHR
IHW
INH
IPNFZ
M1P
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RHX
RIG
RPM
SV3
UKHRP
ITC
RHU
RHW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
AAPBV
7XB
8FK
AZQEC
K9.
PQEST
PQUKI
PRINS
Q9U
5PM
ID FETCH-LOGICAL-c662t-ae4794d915204798ae65dde3129b7a6b12466c4a7897a9c6aeaeb3fd3fcd247b3
IEDL.DBID RPM
ISSN 2291-2789
IngestDate Mon Oct 07 19:36:16 EDT 2024
Tue Sep 17 21:27:37 EDT 2024
Thu Oct 10 19:13:14 EDT 2024
Tue Nov 19 20:57:04 EST 2024
Tue Dec 12 21:19:24 EST 2023
Tue Nov 12 22:43:18 EST 2024
Tue Aug 20 22:09:11 EDT 2024
Fri Dec 06 04:42:37 EST 2024
Fri Sep 17 19:46:01 EDT 2021
Sun Jun 02 18:54:43 EDT 2024
Tue Nov 26 16:45:34 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2017
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c662t-ae4794d915204798ae65dde3129b7a6b12466c4a7897a9c6aeaeb3fd3fcd247b3
Notes Academic Editor: Branka Filipović
ORCID 0000-0003-3350-8356
0000-0001-9236-2268
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758844/
PMID 29441342
PQID 1986175983
PQPubID 2032234
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_0308cd1af8d1439fbcad1a03091b9ace
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5758844
proquest_journals_1986175983
gale_infotracmisc_A586240679
gale_infotraccpiq_586240679
gale_infotracacademiconefile_A586240679
gale_healthsolutions_A586240679
crossref_primary_10_1155_2017_4697194
pubmed_primary_29441342
hindawi_primary_10_1155_2017_4697194
emarefa_primary_1141417
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: Egypt
– name: Oakville
PublicationTitle Canadian journal of gastroenterology & hepatology
PublicationTitleAlternate Can J Gastroenterol Hepatol
PublicationYear 2017
Publisher Hindawi Publishing Corporation
Hindawi
Hindawi Limited
Publisher_xml – name: Hindawi Publishing Corporation
– name: Hindawi
– name: Hindawi Limited
References 22
23
24
25
26
27
28
29
30
31
10
32
11
33
12
34
13
35
14
36
15
37
16
18
19
(17) 2003; 78
1
2
3
4
5
6
7
8
9
20
21
References_xml – ident: 9
  doi: 10.1038/nrdp.2017.34
– ident: 32
  doi: 10.1016/S0016-5107(04)02406-X
– ident: 29
  doi: 10.1186/1756-0500-7-242
– ident: 21
  doi: 10.1007/s00592-013-0516-4
– ident: 16
  doi: 10.1038/sj.ijo.0802305
– ident: 15
  doi: 10.1136/bmj.d6891
– ident: 3
  doi: 10.1016/j.bpg.2014.07.008
– ident: 13
  doi: 10.1053/j.gastro.2005.04.014
– ident: 24
  doi: 10.1097/SLE.0000000000000440
– ident: 22
  doi: 10.1016/j.gie.2009.06.036
– ident: 5
  doi: 10.1111/jpn.12283
– ident: 18
  doi: 10.1001/jama.2014.5988
– ident: 19
  doi: 10.1007/s11695-007-9331-8
– ident: 30
  doi: 10.1007/s11695-012-0829-3
– ident: 31
  doi: 10.1038/sj.ijo.0803094
– ident: 36
  doi: 10.1007/s11695-007-9383-9
– ident: 28
  doi: 10.1136/gutjnl-2013-304490
– ident: 37
  doi: 10.5114/wiitm.2015.55748
– ident: 10
  doi: 10.1053/j.gastro.2010.09.038
– ident: 4
  doi: 10.3390/ijms17060947
– ident: 34
  doi: 10.1016/j.gie.2012.05.023
– ident: 6
  doi: 10.1097/MCO.0000000000000179
– ident: 33
  doi: 10.1002/hep.24127
– ident: 35
  doi: 10.1007/s11695-010-0231-y
– volume: 78
  start-page: 1079
  year: 2003
  ident: 17
  publication-title: American Journal of Clinical Nutrition
  doi: 10.1093/ajcn/78.6.1079
– ident: 1
  doi: 10.1159/000282080
– ident: 27
  doi: 10.1007/BF00280883
– ident: 11
  doi: 10.1002/hep.21327
– ident: 23
  doi: 10.4137/IMI.S31451
– ident: 2
  doi: 10.1053/j.gastro.2011.06.061
– ident: 7
  doi: 10.1089/met.2015.0095
– ident: 20
  doi: 10.1381/0960892055002202
– ident: 25
  doi: 10.1016/j.jhep.2016.12.022
– ident: 12
  doi: 10.1016/j.cgh.2012.10.001
– ident: 14
  doi: 10.1056/NEJMoa021423
– ident: 8
  doi: 10.1016/s0140-6736(14)61316-7
– ident: 26
  doi: 10.4324/9780203987858
SSID ssj0001255932
Score 2.306502
Snippet Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the...
The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric...
Background . The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
hindawi
emarefa
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms Adult
Anesthesia
Biochemistry
Body mass index
Care and treatment
Chronic illnesses
Endoscopy
Fatty liver
Female
Gastric Balloon
Gastrointestinal surgery
Hepatology
Homeostasis
Hospitals
Humans
Insulin
Insulin resistance
Lifestyles
Liver - physiopathology
Liver diseases
Liver Function Tests
Male
Metabolic syndrome
Methylene blue
Middle Aged
Non-alcoholic Fatty Liver Disease - physiopathology
Non-alcoholic Fatty Liver Disease - surgery
Nutrition research
Obesity
Obesity - physiopathology
Obesity - surgery
Patient outcomes
Patients
Retrospective Studies
Statistical analysis
Systematic review
Therapy
Treatment Outcome
Type 2 diabetes
University colleges
Weight control
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJRAXxJvQBXwo4hR1kzh-HFtgVRAtB1qpN2vi2HQllC3tVpX66ztje5cNQuoF7SnxrCPPjO1vxp4ZxnYUgJdtBWXTyVAKHULZSelLOdUB6ikibk_-jsMjeXAivp62pxulvuhOWEoPnBi3S_lUXF9B0D1u7SZ0DvCJDgaqzoDzcfWd1hvGVPKuIFKO1cnq2lQlhXuubr23LRr8ldpFu1BVRoz2o5i2P8bmAj7Depm-f0YG8vX8XzD079uUG9vT7DF7lHEl30vjecLu-eEpe3CYT86fsZvvV0tULn_JA0p-cY07Fk-eMf6FOvwJVMDD8X06iF8M_DhlG0DqC56LB3AYen5EyD1W1UXiGSzx9Te62sE_pZMePh848B_Y_S_Po-vYP2cns8_HHw_KXHehdFLWyxI8pZ3vDW7tlIBekzRxFWwQGnQKZIeQQEonAJmqwDgJHtAkD30TXF8L1TUv2NawGPwrxns0gPW0AYMCETXCEaV67bVCVOVl6NuCvV9x356n9Bo2miVta0lKNkupYPskmjUNJcWOL1BVbFYVe5eqFOxlFuyfb1UCf6pg70jQNsWerie93WspfoZ8bQX7EClo2qNQHOToBRwmJdAaUW6PKN35_LfdaJ2MWnEyu9Gfd7Kq3cGOyUoPbV5zLm1lNMLR1ugGB5pUct1JbRD2NqIumBop64ih45ZhfhazjSOe11qI1_9DAtvsIQ0jubAmbGt5ceXfIKhbdm_j_L0Fr7tFeQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJBAviPEZ1g0_DPEU0SSO7TxuQFUQGxJsUt-si2NvlVA61kyT-Ou5c9zSDKShPDm-OInv7PvdnX1m7EABOFlmkBa19KnQ3qe1lC6VY-0hHyPiduTvOD6R0zPxeVbOYpKk5d8hfNR2aJ5n6h1acQrt7S22pRWt3Po2nW24UhAWh6PI8rzKUtrbuVrifuvxgfIJOfrDRlzAMqzn5PsXZA3fzP-FOW8vndzQRZPH7FEEkfyw5_oOu-faJ-zBcQyTP2W_vl53KEluyT2yeXGD6on3bjD-iRo8Bzqtw_IjirovWn7apxZA6iseTwrg0Db8hGB6OEIXiSfQ4e0vtI6Df-jDOnzecuDfsfkfjgc_sXvGziYfT99P03jIQmqlzLsUHOWYbyrU45RtXhPrcMorEAfUCmSN-l9KKwA7VUFlJThA-9s3hbdNLlRdPGfb7aJ1Lxlv0NrV4wIqZIjIEXso1WinFUIoJ31TJuzNqvfNZZ9LwwQbpCwNcclELiXsiFizpqEM2OEGSoWJA8pQnh3bZOB1g5Cv8rUFLFHAKKsrsC5hLyJj_7wrE3iphL0mRpt-o-l6hJvDkjbLkGMtYW8DBY1xZIqFuFUBf5OyZQ0odweU9nL-02zUjga1OHLt4OGDKGp3dMdoJYcmTjBLk1UasWdZ6QJ_tBfJdSN5hRi3EHnC1EBYBx06rGnnFyG1OIJ3rYV49X9ftsseUrH3SI3Ydnd17fYQo3X1fhihvwFg0jHV
  priority: 102
  providerName: Hindawi Publishing
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgCMQL4nOEFfDDEE_RmsSxkye0AdVAbDywSX2zLv7YKqGkaztN4q_nznG7BiFQnxJfk9h35_vd2b5jbF8BOFlmkBaN9KmovE8bKV0qx5WHfIyI21G84-RUHp-Lr9NyGgNuy7itcj0nhonadoZi5AfoHKOxLeuq-DC_SqlqFK2uxhIad9m9LEdTjvKspmorxoJ4OdQoy_M6S-nQ53rve1mi25-pA_QOVVaLgVUKyfvDCV3Aa9hM1vcvyU2-mf0NjP65p3LLSE0es0cRXfLDXhyesDuufcoenMT182fs1_frFXbXLblH_nc3aLd4Hx_jX-iBF0BlPAw_ouX4ruVnfc4BpF7wWEKAQ2v5KeH3UFsXiSewwtvfaIMH_9Sv9_BZy4H_wMf_dDwEkN1zdj75fPbxOI3VF1IjZb5KwVHyeVujgac09BXxFOfCAgFCo0A2CAykNAJwUBXURoIDdMy9LbyxuVBN8YLttF3rXjJu0Q2uxgXUyBCRIyhRylauUoitnPS2TNi79ejreZ9kQwfnpCw1cUlHLiXsiFizoaHU2OFGt7jQUdM0JeAxNgNfWcSCtW8M4BWtJGVNDcYlbDcy9vZdmcCfSthbYrTuT6BuVF8flnSKhiJuCXsfKEj5kSkG4hkG7Cal0RpQ7g0ozXx2pbdaR4NWVGkz-PN-FLX_DMdoLYc6zjxLfasn2NFeJDcPyWsEv4XIE6YGwjoY0GFLO7sMOccR1VeVEK_-_co99pA-sA9RjdjOanHtXiNoWzVvgmb-Bl6bPA8
  priority: 102
  providerName: ProQuest
Title Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre
URI https://search.emarefa.net/detail/BIM-1141417
https://dx.doi.org/10.1155/2017/4697194
https://www.ncbi.nlm.nih.gov/pubmed/29441342
https://www.proquest.com/docview/1986175983
https://pubmed.ncbi.nlm.nih.gov/PMC5758844
https://doaj.org/article/0308cd1af8d1439fbcad1a03091b9ace
Volume 2017
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtx8Zeyr7nNsv00LEnN_GXJD82XUM2lix0LeRNyLLcGlonS10K--t3J8tZPAaDETDYkuVIdyf97nR3IuSIK2VYEig_yljhx6Io_Iwx47OhKFQ4BMRt0N4xnbHJZfxlkSx2SNLGwlinfZ2Vx9XN7XFVXlvfytWtHrR-YoP59BQghhBxPNglu7D8bqnojWEFQLI9mCwM08DHSM_W4T1JQNcP-ABUQg7KOyYCTgEORHHYWZVs8n4boavgXm0m68fXqCY_lH8Do3_6VG4tUuNnZN-hS3rS9OI52THVC_Jk6vbPX5Kf3-5rYDFzRwug__IB1i3a2MfoZ2zwSuExHpqOcDt-WdGLJucA1F5Td4QAVVVOZ4jf7dm6UHmsanj8FR086Kdmv4eWFVX0OzR_Y6g1IJtX5HJ8dnE68d3pC75mLKx9ZTD5fJ7CAo9p6AXSFObCCABCxhXLABgwpmMF48tVqpkyChTzIo8KnYcxz6LXZK9aVuYtoTmowWIYqRRoE4cASjjPhREcsJVhRZ545EM7-nLVJNmQVjlJEokEk45gHhkhaTZ1MDW2fbBcX0nHIBIT8Og8UIXIAQumRaYV3OFOUpClShuPvHGE_f2tIIYf98h7JLRsIlA3oi9PEoyiQYubRz7aGij8QBStXAwDdBPTaHVqHnZq6lX5Q26V9jqlINK68_KRY7V_DEev5UPpZp47GaQCQGmSigg62rDkppGW2z3CO8zaGdBuCYigzTnuRO7gv988JE_xvzfWqx7Zq9f35h3guTrrgxQveJ88Gp3N5ud9axWB62w-hev5ZNG38v0LnBBKkw
link.rule.ids 230,314,727,780,784,863,864,877,878,885,2102,12056,21388,27924,27925,31719,33744,43310,43805,53791,53793,73745,74302
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELegEx8viG_CCvPDEE_Rmi_beUIrrOqgLQg6aW_WxXG2Sijp2kyT-Ou5S9yuQQiUp8QXJ_bd2b8723eMHUoAK5IA_CgThR-rovAzIawvBqqAcICI25K_YzoT47P483ly7hxua7etcjMmNgN1XhnykR-hcYyTbZKq6MPyyqesUbS66lJo3GV7FDk96bG94cns2_cdLwsi5iZLWRimgU_HPje735MEDf9AHqF9KIM07sxLTfj-5owu4D1sh-t7l2Qo3yz-Bkf_3FW5M02NHrNHDl_y41YgnrA7tnzK7k_dCvoz9uvrdY0NtmteoARUNzhz8dZDxk-pwgugRB6GD2lBvir5vI06gNQr7pIIcChzPiME32TXReIR1Ph4Qls8-Kd2xYcvSg78B1b_0_LGhWyfs7PRyfzj2Hf5F3wjRFj7YCn8fJ7iFE-B6BVxFUfDCCFCJkFkCA2EMDFgp0pIjQALaJoXeVSYPIxlFr1gvbIq7SvGczSE1SCCFBkShwhLpMyVVRLRlRVFnnjs3ab39bINs6Eb8yRJNHFJOy55bEis2dJQcOzmQbW60E7XNIXgMXkAhcoRDaZFZgDvaC0pyFIw1mMvHWNvvxXEeEmPHRCjdXsGdav8-jihczTkc_PY-4aC1B-ZYsCdYsBmUiCtDuV-h9IsF1d6p7TfKUWlNp2XD52o_ac7-hs51G7sWetbTcGGtiK5rSRMEf5Gcegx2RHWTod2S8rFZRN1HHG9UnH8-t-fPGAPxvPpRE9OZ1_22UP62dZh1We9enVt3yCEq7O3Tk9_A8DBQGU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELegExMviG_CCvPDEE9Rm8RxnCe0slUbbGWCTdqbdXHsrRJKurbTJP567hK3axAC9SnxNYl957ufz-c7xvYyACvTCMKkkC4UyrmwkNKGcqgcxENE3Jb8HacTeXQhvlymlz7-aeHDKlc6sVHUZW3IRz7AxTEa2zRXycD5sIizg_Gn2U1IFaRop9WX03jIttAqDuMe2xodTs6-b3hcED03FcviOI9COgK6ioRP00FMiaRxrZhFuejYqCaVf3NeF_Aa1qr70TUtmu-mf4Omf0ZYbpis8VP2xGNNvt8KxzP2wFbP2fap301_wX59u11i5-2CO5SG-g6tGG-9ZfyYHngFVNTD8BFtztcVP28zECD1nPuCAhyqkk8IzTeVdpF4DEu8fULhHvyg3f3h04oD_4GP_2l54062L9nF-PD881HoazGERsp4GYKlVPRljuaektIr4jBqxgThQpGBLBAmSGkE4KBmkBsJFnCZ7srEmTIWWZG8Yr2qruwbxktcFKthAjkyRMQIUbKsVFZliLSsdGUasA-r0dezNuWGbpYqaaqJS9pzKWAjYs2ahhJlNzfq-ZX2805TOh5TRuBUicgwd4UBvKJ9pajIwdiAvfaMvX9XJPCXBWyXGK3b86hrRaD3UzpTQ_63gH1sKEgVIFMM-BMN2E1KqtWh3OlQmtn0Rm-09jutOMFN5897XtT-Mxz9lRxqr4cW-n7WYEdbkVw_JM4RCiciDljWEdbOgHZbqul1k4EcMb5SQrz99yt32TZOUX1yPPm6wx7Tt7a-qz7rLee39h2iuWXx3k_T3xdiRJI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Outcomes+following+Serial+Intragastric+Balloon+Therapy+for+Obesity+and+Nonalcoholic+Fatty+Liver+Disease+in+a+Single+Centre&rft.jtitle=Canadian+journal+of+gastroenterology+%26+hepatology&rft.au=Nguyen%2C+Vi&rft.au=Li%2C+Jiawei&rft.au=Gan%2C+Jaslyn&rft.au=Cordero%2C+Paul&rft.date=2017-01-01&rft.pub=Hindawi&rft.issn=2291-2789&rft.eissn=2291-2797&rft.volume=2017&rft_id=info:doi/10.1155%2F2017%2F4697194&rft.externalDocID=10_1155_2017_4697194
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2291-2789&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2291-2789&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2291-2789&client=summon